The Famous vs. The Inconvenient – or Why Use 3D-Culture Systems Eric Gottwald, Karlsruhe Institute of Technology, speaking at Stem Cells & Bioprocessing Europe 2012.
Drug-induced Hepatotoxicity Prediction Using Three-Dimensional Culture Models in High Content Screening Context Dr Thierry Dorval, Institut Pasteur Korea, speaking at European Laboratory Automation 2012.
Novel, Simple Technology for Creating Physiologically Relevant 3-D Tissue Models Rosemary Drake, TAP Biosystems, speaking at European Laboratory Automation 2012.
Joint Talk - Deciphering the Cell with GE Healthcare Cell Technologies / The Importance of High Content Analysis for Stem Cell Culture, Differentiation and Media Development Dr. Bergendahl, Miltenyi Biotec GmbH, speaking at European Laboratory Automation 2012.
Dynamic Cell Culture for Drug Discovery: Stretching Mechanotransduction from the Lung to the Lab Dr. Sanjit Nirmalanandhan, University of Kansas Medical Center, speaking at Cell Culture 2012.
Novel Angiogenic Model Based on Stable, Fluorecently Labled Cell Lines Amenable to High Content Screening Natalie Prigozhina, Sanford-Burnham Medical Research Institute, speaking at Cell Culture 2012
Understanding Cell Transitions at Single-Cell Level Dr Anders Ståhlberg, University of Gothenburg in Sweden, speaking at Single Cell Analysis Europe 2012.
The Influence of Structures on Cellular Processes During Differentiation of neuronal Stem Cells - Adhesion Clemens Holzer, Medical University Graz, speaking at Cell Culture 2012
Challenges for Stem Cell Bioprocessing - Scale-Up or Scale-Out? Christopher Hewitt, Loughborough University, speaking at Cell Culture 2012